Forced hepatic overexpression of CEACAM1 curtails diet-induced insulin resistance

Diabetes

Volumn 64, Issue 8, 2015, Pages 2780-2790

  Al Share, Qusai Y ^a   Deangelis, Anthony M ^a   Lester, Sumona Ghosh ^a   Bowman, Thomas A ^a   Ramakrishnan, Sadeesh K ^a   Abdallah, Simon L ^a   Russo, Lucia ^a   Patel, Payal R ^a   Kaw, Meenakshi K ^a   Raphael, Christian K ^a   Kim, Andrea Jung ^a,b   Heinrich, Garrett ^a,b   Lee, Abraham D ^a,b   Kim, Jason K ^c   Kulkarni, Rohit N ^d   Philbrick, William M ^e   Najjar, Sonia M ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; INSULIN; TRIACYLGLYCEROL; CD66 ANTIGENS; CELL ADHESION MOLECULE; FATTY ACID; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET INDUCED INSULIN RESISTANCE; ENERGY EXPENDITURE; FATTY ACID OXIDATION; HYPERINSULINEMIA; INSULIN CLEARANCE; INSULIN RESISTANCE; LIPID DIET; LIPID LIVER LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BLOOD; ENERGY METABOLISM; GENETICS; HYPERINSULINISM; LIVER; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; CELL ADHESION MOLECULES; DIET, HIGH-FAT; ENERGY METABOLISM; FATTY ACIDS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; LIVER; MICE; MICE, TRANSGENIC;

EID: 84964697318     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1772     Document Type: Article

References (50)

1. Dankner R, Chetrit A, Shanik MH, Raz I, Roth J. Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: A preliminary report. Diabetes Care 2009;32:1464-1466.
2. Pories WJ, Dohm GL. Diabetes: have we got it all wrong? Hyperinsulinism as the culprit: surgery provides the evidence. Diabetes Care 2012;35:2438-2442.
3. Corkey BE. Banting lecture 2011: hyperinsulinemia: cause or consequence? Diabetes 2012;61:4-13.
4. Svedberg J, Björntorp P, Smith U, Lönnroth P. Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 1990;39:570-574.
5. Osborne TF. Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J Biol Chem 2000;275: 32379-32382.
6. Najjar SM, Russo L. CEACAM1 loss links inflammation to insulin resistance in obesity and non- Alcoholic steatohepatitis (NASH). Semin Immunopathol 2014; 36:55-71.
7. Kabir M, Catalano KJ, Ananthnarayan S, et al. Molecular evidence supporting the portal theory: A causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 2005;288:E454-E461.
8. Scherer T, Lindtner C, Zielinski E, O'Hare J, Filatova N, Buettner C. Short term voluntary overfeeding disrupts brain insulin control of adipose tissue lipolysis. J Biol Chem 2012;287:33061-33069.
9. Pereira S, Park E, Mori Y, et al. FFA-induced hepatic insulin resistance in vivo is mediated by PKCd, NADPH oxidase, and oxidative stress. Am J Physiol Endocrinol Metab 2014;307:E34-E46.
10. Chen S, Lam TK, Park E, et al. Oleate-induced decrease in hepatocyte insulin binding is mediated by PKC-delta. Biochem Biophys Res Commun 2006; 346:931-937.
11. Boden G. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr Diab Rep 2006;6:177-181.
12. Kim F, Pham M, Maloney E, et al. Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol 2008;28:1982-1988.
13. Strissel KJ, DeFuria J, Shaul ME, Bennett G, Greenberg AS, Obin MS. T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity (Silver Spring) 2010;18:1918-1925.
14. Lee YS, Li P, Huh JY, et al. Inflammation is necessary for long- Term but not short- Term high-fat diet-induced insulin resistance. Diabetes 2011;60: 2474-2483.
15. Meistas MT, Margolis S, Kowarski AA. Hyperinsulinemia of obesity is due to decreased clearance of insulin. Am J Physiol 1983;245:E155-E159.
16. Jones CN, Abbasi F, Carantoni M, Polonsky KS, Reaven GM. Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am J Physiol Endocrinol Metab 2000;278:E501-E508.
17. Ader M, Stefanovski D, Kim SP, et al. Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog. Obesity (Silver Spring) 2014;22:1238-1245.
18. Pivovarova O, Bernigau W, Bobbert T, et al. Hepatic insulin clearance is closely related to metabolic syndrome components. Diabetes Care 2013;36: 3779-3785.
19. Lee CC, Haffner SM, Wagenknecht LE, et al. Insulin clearance and the incidence of type 2 diabetes in Hispanics and African Americans: The IRAS Family Study. Diabetes Care 2013;36:901-907.
20. Escobar O, Mizuma H, Sothern MS, et al. Hepatic insulin clearance increases after weight loss in obese children and adolescents. Am J Med Sci 1999; 317:282-286.
21. Formisano P, Najjar SM, Gross CN, et al. Receptor-mediated internalization of insulin. Potential role of pp120/HA4, a substrate of the insulin receptor kinase. J Biol Chem 1995;270:24073-24077.
22. Poy MN, Yang Y, Rezaei K, et al. CEACAM1 regulates insulin clearance in liver. Nat Genet 2002;30:270-276.
23. DeAngelis AM, Heinrich G, Dai T, et al. Carcinoembryonic antigen-related cell adhesion molecule 1: A link between insulin and lipid metabolism. Diabetes 2008;57:2296-2303.
24. Xu E, Dubois MJ, Leung N, et al. Targeted disruption of carcinoembryonic antigen-related cell adhesion molecule 1 promotes diet-induced hepatic steatosis and insulin resistance. Endocrinology 2009;150:3503-3512.
25. Najjar SM, Yang Y, Fernström MA, et al. Insulin acutely decreases hepatic fatty acid synthase activity. Cell Metab 2005;2:43-53.
26. Lee W. The CEACAM1 expression is decreased in the liver of severely obese patients with or without diabetes. Diagn Pathol 2011;6:40.
27. Walsh A, Ito Y, Breslow JL. High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3. J Biol Chem 1989;264: 6488-6494.
28. Kim JY, Koves TR, Yu GS, et al. Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle. Am J Physiol Endocrinol Metab 2002;282:E1014-E1022.
29. Heinrich G, Ghosh S, Deangelis AM, et al. Carcinoembryonic antigen-related cell adhesion molecule 2 controls energy balance and peripheral insulin action in mice. Gastroenterology 2010;139:644-652, e1.
30. Taub M, Wang Y, Szczesny TM, Kleinman HK. Epidermal growth factor or transforming growth factor alpha is required for kidney tubulogenesis in matrigel cultures in serum-free medium. Proc Natl Acad Sci U S A 1990;87: 4002-4006.
31. Andrikopoulos S, Blair AR, Deluca N, Fam BC, Proietto J. Evaluating the glucose tolerance test in mice. Am J Physiol Endocrinol Metab 2008;295: E1323-E1332.
32. Rader DJ. Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest 2006;116:3090-3100.
33. Najjar SM. Regulation of insulin action by CEACAM1. Trends Endocrinol Metab 2002;13:240-245.
34. Inagaki T, Dutchak P, Zhao G, et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 2007;5:415-425.
35. Kunisch E, Fuhrmann R, Roth A, Winter R, Lungershausen W, Kinne RW. Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis 2004;63:774-784.
36. Emanuelli B, Vienberg SG, Smyth G, et al. Interplay between FGF21 and insulin action in the liver regulates metabolism. J Clin Invest 2014;124:515-527.
37. Owen BM, Ding X, Morgan DA, et al. FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss. Cell Metab 2014; 20:670-677.
38. Park SY, Cho YR, Kim HJ, et al. Unraveling the temporal pattern of dietinduced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes 2005;54:3530-3540.
39. Liu J, Zhou L, Xiong K, et al. Hepatic cannabinoid receptor-1 mediates dietinduced insulin resistance via inhibition of insulin signaling and clearance in mice. Gastroenterology 2012;142:1218-1228, e1.
40. Mittelman SD, Van Citters GW, Kim SP, et al. Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response. Diabetes 2000;49:2116-2125.
41. Erdmann J, Kallabis B, Oppel U, Sypchenko O, Wagenpfeil S, Schusdziarra V. Development of hyperinsulinemia and insulin resistance during the early stage of weight gain. Am J Physiol Endocrinol Metab 2008;294:E568- E575.
42. Bakker LE, van Schinkel LD, Guigas B, et al. A 5-day high-fat, high-calorie diet impairs insulin sensitivity in healthy, young South Asian men but not in Caucasian men. Diabetes 2014;63:248-258.
43. Fisher FM, Chui PC, Nasser IA, et al. Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets. Gastroenterology 2014;147:1073-1083 e1076.
44. Chakravarthy MV, Pan Z, Zhu Y, et al. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab 2005;1:309-322.
45. Pantelic M, Chen I, Parker J, Zhang P, Grunert F, Chen T. Retinoic acid treated HL60 cells express CEACAM1 (CD66a) and phagocytose Neisseria gonorrhoeae. FEMS Immunol Med Microbiol 2004;42:261-266.
46. Li Y, Wong K, Walsh K, Gao B, Zang M. Retinoic acid receptor b stimulates hepatic induction of fibroblast growth factor 21 to promote fatty acid oxidation and control whole-body energy homeostasis in mice. J Biol Chem 2013;288:10490-10504.
47. Rosenbaum M, Leibel RL. Leptin: A molecule integrating somatic energy stores, energy expenditure and fertility. Trends Endocrinol Metab 1998;9:117-124.
48. Cornu M, Oppliger W, Albert V, et al. Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21. Proc Natl Acad Sci U S A 2014;111:11592-11599.
49. Wisløff U, Najjar SM, Ellingsen O, et al. Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 2005;307:418-420.
50. Bowman TA, Ramakrishnan SK, Kaw M, et al. Caloric restriction reverses hepatic insulin resistance and steatosis in rats with low aerobic capacity. Endocrinology 2010;151:5157-5164.